Aging populations, the drive for better preventive medicines, and the increasing reliance on the private sector to help societies pay for ballooning healthcare costs continue to make healthcare a prized sector, with returns higher than in most other industries.
That’s as true in Europe as it is elsewhere in the world. Yet private equity participation in the region remains stubbornly low. Private equity firms have struggled to find attractive opportunities due to the fragmented and patchwork nature of European healthcare markets as well as strong competition between investors.
Our latest report examines how private equity can increase its presence in the European healthcare market.
Download the full report on which this article is based, European healthcare—a golden opportunity for private equity(PDF–1.1MB).